In early trading on Monday, shares of Idexx Laboratories, topped the list of the day's best performing components of the Nasdaq 100 index, trading up 10.3%. Year to date, Idexx Laboratories ...

Below is Validea's guru fundamental report for IDEXX LABORATORIES INC (IDXX). Of the 22 guru strategies we follow, IDXX rates highest using our P/B Growth Investor model based on the published ...

Truist Financial Corp grew its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 13.9% in the 4th ...

Idexx Laboratories (IDXX) came out with quarterly earnings of $2.62 per share, beating the Zacks Consensus Estimate of $2.40 per share. This compares to earnings of $2.32 per share a year ago.

In early trading on Monday, shares of Idexx Laboratories topped the list of the day's best performing components of the S&P 500 index, trading up 10.3%. Year to date, Idexx Laboratories, registers ...

Investors in IDEXX Laboratories, Inc. IDXX need to pay close attention to the stock based on moves in the options market lately. That is because the Mar 21, 2025 $290.00 Call had some of the ...

Investors in Idexx Laboratories, Inc. (Symbol: IDXX) saw new options become available today, for the September 19th expiration. One of the key inputs that goes into the price an option buyer is ...

IDEXX Laboratories, Inc. IDXX is set to release fourth-quarter 2024 results on Feb. 3, before the opening bell. Find the latest EPS estimates and surprises on Zacks Earnings Calendar. In the last ...

Veterinary diagnostics specialist Idexx Laboratories (NASDAQ:IDXX) reported fourth-quarter earnings on Monday, Feb. 3, that topped analysts' consensus top- and bottom-line estimates. Revenue for ...

A substantial insider activity was disclosed on February 12, as Erickson, Executive Vice President at IDEXX Laboratories (NASDAQ:IDXX), reported the exercise of a large sell of company stock options.

A substantial insider sell was reported on February 10, by M. Anne Szostak, Director at IDEXX Laboratories (NASDAQ:IDXX), based on the recent SEC filing. What Happened: Szostak's recent move ...